Results 161 to 170 of about 14,308 (181)

Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C

Clinical Gastroenterology and Hepatology, 2009
David Nelson, Gary L Davis, Erik Pulkstenis   +2 more
exaly  

Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients

British Journal of Dermatology, 2002
Olivier Dereure
exaly  

Interferon Alfa and Autoimmunity

Southern Medical Journal, 1996
openaire   +1 more source

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

Journal of Hepatology, 2006
G Mani Subramanian, E Jenny Heathcote
exaly  

The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanoma

Expert Opinion on Drug Safety, 2017
Wen-Jen Hwu, Van Anh Trinh
exaly  

Interferon alfa-2b.

2011
openaire   +1 more source

A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a

Cancer, 1993
L Janisch, N J Vogelzang
exaly  

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3

Gastroenterology, 2010
Robert Flisiak, Erik Pulkstenis, Maribel Rodriguez-Torres   +2 more
exaly  

Interferon Alfa-2b

2018
openaire   +2 more sources

Interferon-alfa, interferon-λ and hepatitis C

Nature Genetics, 2009
openaire   +1 more source